References
Cardani R, Mancinelli E, Sansone V, Rotondo G, Meola G (2004) Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy. Eur J Histochem 48:437–442
Meola G (2013) Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies. Acta Myologica 32:154–165
Cagnetti C, Buratti L, Foschi N, Balestrini S, Provinciali L (2014) Generalized epilepsy in a patient with myotonic dystrophy type 2. Neurol Sci 35:489–490. doi:10.1007/s10072-013-1578-3
Franc DT, Muetzel RL, Robinson PR, Rodriguez CP, Dalton JC, Naughton CE, Mueller BA, Wozniak JR, Lim KO, Day JW (2012) Cerebral and muscle MRI abnormalities in myotonic dystrophy. Neuromuscul Disord 22:483–491. doi:10.1016/j.nmd.2012.01.003
Bugiardini E, Meola G; DM-CNS Group (2014) Consensus on cerebral involvement in myotonic dystrophy: workshop report: May 24–27, 2013, Ferrere (AT). Italy. Neuromuscul Disord 24:445–452. doi:10.1016/j.nmd.2014.01.013
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Funding
No funding.
Rights and permissions
About this article
Cite this article
Giuliano, L., Sofia, V., Cardani, R. et al. Drug resistant focal epilepsy in a patient with myotonic dystrophy type 2: casual or causal association?. Neurol Sci 37, 1867–1868 (2016). https://doi.org/10.1007/s10072-016-2619-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-016-2619-5